SBIR/STTR Research Award

A SELECTION PROCEDURE FOR ENHANCING THE EXPRESSION OF MALIGNANT TRANSFORMATION IN PRIMARY SYRIAN HAMSTER EMBRYO CELLS.

Award identifier 87f2f74dbcccdabf8961e035c3c1cce4207a609d11d18f2af9a0cae837ebe4cfAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1988

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Microbiological Associates Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE PURPOSE OF THIS PROJECT IS TO IMPROVE THE HAMSTER EMBRYO CELL CLONAL TRANSFORMATION ASSAY TO INCREASE THE MORPHOLOGICAL TRANSFORMATION RATE AND INTRODUCE AN ADDITIONAL ENDPOINT, COLONY FORMATION IN SOFT AGAROSE. THE METHODOLOGY DESCRIBED INTRODUCES A SELECTIVE STEP WHICH ENTAILS SUSPENSION OF CHEMICALLY-TREATED AND CONTROL CELLS IN LIQUID MEDIUM OVER A SOLID AGAR BASE FOR UP TO FOUR DAYS,FOLLOWED BY RESEEDING INTO MONOLAYER CULTURE AND GROWTH TO CONFLUENCE. THE SELECTIVE STEP MAY BE REPEATED IF NECESSARY. CELLS ARE THEN SEEDED AT LOW NUMBERS IN 60 MM PETRI DISHES TO SCORE FOR ALTERED COLONIES, PLATED IN SOFT AGAROSE OR SUBCULTURED INTO FLASKS AT HIGH DENSITY. DURING PHASE I THE NUMBER OF DAYS IN SUSPENSION WOULD BE VARIED TO MAXIMIZE REDUCTION IN NORMAL CELL NUMBERS UTILIZING ONE OR TWO KNOWN CARCINOGENIC CHEMICALS. IN PHASE II ADDITIONAL CHEMICALS WOULD BE EXAMINED, INCLUDING CARCINOGENS, NONCARCINOGENS AND CHEMICALS POSSIBLY REQUIRING METABOLIC ACTIVATION, TO VALIDATE THE SYSTEM. IN ADDITION THE APPLICATION OF MOLECULAR ENDPOINTS (E.G. ONCOGENE ENDPOINTS)WILL BE INVESTIGATED. THE COMMERCIAL APPLICATION OF THIS WORK IS THE USE OF A SCREENING SYSTEM FOR THE IDENTIFICATIONOF CARCINOGENS WHICH IS MORE OBJECTIVE THAN THOSE CURRENTLY IN USE AND MORE CLOSELY ASSOCIATED WITH TUMORIGENICITY.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.